Researchers examine how sleep impacts inflammation and recovery following a heart attack.
GSK to acquire Chimagen’s CMG1A46 for autoimmune treatment
The acquisition of CMG1A46 is a strategic move to address the diverse manifestations of lupus and the ongoing burden it places on patients. Credit: Indypendenz/Shutterstock.